EUnetHTA was established to create an effective and sustainable network for HTA across Europe – we work together to help developing reliable, timely, transparent and transferable information to contribute to HTAs in European countries.

EUnetHTA supports collaboration between European HTA organisations that brings added value at the European, national and regional level through:

–          facilitating efficient use of resources available for HTA

–          creating a sustainable system of HTA knowledge sharing

–          promoting good practice in HTA methods and processes.

To this aim two Joint actions were set up:

–          EUnetHTA Joint Action 1 (2010-2012)

The overarching objective of the EUnetHTA Joint Action 1 (JA1) on Health Technology Assessment (HTA) including work on relative effectiveness of pharmaceuticals is to put into practice an effective and sustainable HTA collaboration in Europe that brings added value at the European, national and regional level. The JA brought together HTA agencies and institutional producers of HTA and assessments of pharmaceuticals across Europe. The JA1 facilitates solutions to overcome barriers to collaboration and makes it possible to deliver context specific reporting of HTA results.

–          EUnetHTA Joint Action 2 (2012-2015)

The general objective of the EUnetHTA Joint Action 2 (JA2) on Health Technology Assessment (HTA) is to strengthen the practical application of tools and approaches to cross-border HTA collaboration. The JA2 aims at bringing collaboration to a higher level resulting in better understanding for the Commission and Member States of the ways to establish a sustainable structure for HTA in the EU. Specifically, the JA2 will develop a general strategy, principles and an implementation proposal for a sustainable European HTA collaboration according to the requirements of Article 15 of the Directive for cross-border healthcare.

CPME is partner of the EUnetHTA Joint Action 2 (as it was for the JA1) through its Stakeholder Forum. Dr Jacques de Haller is representing CPME in the Joint Action 2.